1. Introduction {#sec0005}
===============

Erythropoiesis is the process by which red blood cells are produced. It occurs within the broader frame of haematopoiesis, the process which generates all blood cells. The dynamics of haematopoiesis has been extensively modelled mathematically in the past decades, with the first historical models published as early as fifty years ago \[[@ref001]\] (for a review of the history of haematopoiesis modelling in general, see \[[@ref003]\]). Models of haematopoiesis have improved the understanding of both the processes they describe \[[@ref004]\], and the mathematical tools they use. These models comprise non-exhaustively Differential Equations (DE, either ordinary \[[@ref001]\], partial, which can be structured by age, maturity, or a combination of these \[[@ref006]\], or even delay differential equations \[[@ref007]\]) and agent-based models \[[@ref008]\]. They can be fully deterministic \[[@ref005]\] or can include a more or less prominent stochastic component \[[@ref009]\].

Recent works specifically focusing on erythropoiesis comprise DE-based models \[[@ref012]\] and multi-scale descriptions of these phenomena \[[@ref014]\].

All these works aim at modeling the *in vivo* physiological processes, *i.e.* the processes occurring in a whole organism. Those processes are related to numerous pathologies, for which clinical data are very sparse and must be acquired on experimentally prohibitive time-scales, which complicates their study. Modeling has therefore provided significant insights into these pathologies \[[@ref004]\]. On the contrary, the *in vitro* context, *i.e.* the process that takes place in cells grown in culture, is much simpler to characterize experimentally. Yet, to our knowledge, no modeling study has focused on it so far. Since the *in vitro* differentiation is an experimental tool of choice for the study of cellular decision-making \[[@ref017]\], we propose to develop a model for the dynamics of the *in vitro* erythropoiesis.

Moreover, the current models of erythropoiesis suffer from one major drawback: the weakness of their parameterization, which can fall within three categories.

A vast majority of the existing models of erythropoiesis are based on experimental parameter values from the literature. In some cases these values are used in other contexts that those in which they were obtained (typically, in other species \[[@ref012]\]).

In other cases, the parameter values of a model are chosen arbitrarily to reproduce a qualitative behaviour. Apart from this qualitative fit, such approaches do not provide any information regarding the validity of the values \[[@ref016]\].

Finally, when the parameters of a model are estimated to reproduce a dataset, the precision of this estimation is seldom investigated \[[@ref020]\]. By this, we mean that depending on the algorithmic details of the estimation, it is possible that several values of the parameters might render the same fit to the data. In this case the model is said to be unidentifiable.

A model is said to be identifiable if and only if it is possible to infer a unique value for each of its parameter by comparing its output to experimental data. Otherwise it is unidentifiable. A model can be non-identifiable for several reasons \[[@ref021]\].

Structural identifiability is related to the structure of the model, and the observed variables. A model is structurally unidentifiable when several of its parameters are redundant, meaning that they can vary in such a manner that the measured output of the model is not affected \[[@ref021]\]. A variety of methods, based on different approaches, can be used to assess the structural identifiability of a dynamic model. These include, non-exhaustively, the Taylor series method \[[@ref024]\], the similarity transformation \[[@ref025]\], the generating series method \[[@ref026]\], and the profile likelihood approach \[[@ref022]\]. A review of these methods is provided in \[[@ref021]\] and their performance is assessed in \[[@ref023]\].

Practical Identifiability is related to the quantity and quality of the data used for model calibration. If the data is too sparse or too noisy to estimate all parameters together, then the model is said to be practically unidentifiable \[[@ref021]\]. Essentially three kinds of frequentist methods can be used to assess the practical identifiability of a model: methods based on the Fisher Information Matrix (FIM) \[[@ref029]\], which use a parabolic approximation of the likelihood function, profile-likelihood-based methods \[[@ref022]\], and bootstrapping, which is based on the resampling of the data \[[@ref030]\]. FIM-based methods are less computationally demanding, because they require the fewest parameter estimation steps \[[@ref031]\], but due to their parabolic approximation they are proven to render biased results \[[@ref022]\]. On the other hand, the profile likelihood-based method is computationally cheaper than bootstrapping \[[@ref031]\], and is proven to detect both structural and practical unidentifiabilities \[[@ref022]\].

Despite the growth of the interest in identifiability and related concepts among the biological systems modelling community \[[@ref021]\] the identifiability of models remains seldom investigated \[[@ref020]\]. With this in mind, the most rigorous way to design and calibrate a model of erythropoiesis seems to use dedicated experiments to determine its parameter values. Once these values have been determined, one should then test the identifiability of the model before using it for any prediction.

In this paper, we aim at developing an identifiable model for the dynamics of the *in vitro* erythroid differentiation. The data that we generated to calibrate it consists in counts of different cell sub-populations at regularly spaced time-points during the course of proliferation and differentiation of chicken erythroid progenitors. We start by formulating different possible structures for the dynamics of the system, and for the distribution of residuals. We select the best structure and distribution using classical information criteria. We then assess the identifiability of our model using an approach based on the profile likelihood concept. Finally, we test the adaptation of our model in a perturbed context, when cells are exposed to rapamycin, a drug which is known to affect the dynamics of differentiation, although its precise effect on proliferation and differentiation remains unclear. Since our model is identifiable, it is possible to quantify the effect of the drug on each of its parameters.

2. Methods {#sec0010}
==========

2.1. Experimental Data {#sec0015}
----------------------

### 2.1.1. T2EC cell culture {#sec0020}

The experimental setting from which all the data used in this study were obtained consists in a culture of chicken erythroid progenitors called T2EC that were extracted from the bone marrow of 19 days-old SPAFAS white leghorn chickens embryos (INRA, Tours, France). They may either be maintained in a proliferative state or induced to differentiate into mature erythrocytes depending on the medium in which they are grown \[[@ref035]\].

### 2.1.2. LM1 experiment {#sec0025}

In the self-renewal medium (referred to as the LM1 medium) the progenitors self-renew, and undergo successive rounds of division. LM1 medium was composed of *α*-MEM medium supplemented with 10% Foetal bovine serum (FBS), 1 mM HEPES, 100 nM *β*-mercaptoethanol, 100 U/mL penicillin and streptomycin, 5 ng/mL TGF-*α*, 1 ng/mL TGF-*β* and 1 mM dexamethasone as previously described \[[@ref035]\]. After 10 days in LM1, the culture is composed at \>99% of erythroid progenitors cells \[[@ref036]\]. Cell population growth was evaluated by counting living cells in a 30 μL sample of the 1mL culture using a Malassez cell and Trypan blue staining (SIGMA), which specifically dyes dead cells ([Fig. 1](#isb-13-isb190471-g001){ref-type="fig"}-A), each 24h after the beginning of the experiment.

![Experimental context. A: In LM1 medium the culture is only composed of living and dead cells in the self-renewal state. The amount of living cells can be measured by trypan blue staining. B: In DM17 medium, the culture is a mixture of living and dead, self-renewing and differentiating cells. The amount of living cells can be measured by trypan blue staining. The amount of differentiated cells can be measured by benzidine staining. C: Data used to calibrate the models. Black dots are the results of a single experiment in the control situation (no treatment). Red triangles are the results of the same experiment under rapamycin treatment. Both conditions were obtained with the same initial populations, so the black dot and red triangle are the same at *t* = 0. For readability, living cell counts are displayed in log-scale, and differentiated cell counts are displayed as a fraction of the total living cell count. D: Commitment experiment. If the differentiating cells are switched back to LM1 after 24h of differentiation the culture starts proliferating again (upper trajectory). If the cells are switched back to LM1 after 48h, the culture stagnates (lower trajectory).](isb-13-isb190471-g001){#isb-13-isb190471-g001}

### 2.1.3. DM17 experiment {#sec0030}

T2EC can be induced to differentiate by removing the LM1 medium and placing cells into 1mL of the differentiation medium, referred to as DM17 (*α*-MEM, 10% foetal bovine serum (FBS), 1 mM HEPES, 100 nM *β*-mercaptoethanol, 100 U/mL penicillin and streptomycin, 10 ng/mL insulin and 5% anaemic chicken serum (ACS)). Upon the switching of culture medium, a fraction of the progenitors undergoes differentiation and becomes erythrocytes. The culture thus becomes a mixture of differentiated and undifferentiated cells, with some keeping proliferating. Cell population differentiation was evaluated by counting differentiated cells in a 30 μL sample of the culture using a counting cell and benzidine (SIGMA) staining which stains haemoglobin in blue ([Figure 1](#isb-13-isb190471-g001){ref-type="fig"}B). A parallel staining with trypan blue still gives access to the overall numbers of living cells ([Figure 1](#isb-13-isb190471-g001){ref-type="fig"}B). Consequently, the data available from this experiment are the absolute numbers of differentiated cells, as well as the total number of living cells (which comprises both self-renewing and differentiated cells) at the same time points as in the LM1 experiment. The data presented on [Figs 1](#isb-13-isb190471-g001){ref-type="fig"}C and [5](#isb-13-isb190471-g005){ref-type="fig"}A are the total number of living cells in the culture, and the fraction of differentiated cells, extrapolated from the counting.

### 2.1.4. Rapamycin treatment {#sec0035}

In the control condition, cells were grown in their regular medium with 0.1% DMSO ([Figure 1](#isb-13-isb190471-g001){ref-type="fig"}C, black dots). In the treated condition, cells were grown in the presence of rapamycin (Calbiochem), a chemical drug known to affect both the number of living cells in culture, and the proportion of differentiated cells \[[@ref036]\], as displayed on [Figure 1](#isb-13-isb190471-g001){ref-type="fig"}C. Cells were treated with Rapamycin at 50 nM just after switching them to the DM17 medium. It should be noticed that the very same original culture was used to initiate all the experiments presented on [Figure 1](#isb-13-isb190471-g001){ref-type="fig"}C (in the LM1 and DM17 media, as well as in the treated and untreated conditions).

### 2.1.5. Commitment experiment {#sec0040}

Another piece of experimental data that will be of use for calibrating our models is the result of the commitment experiment. The full protocols and results of this experiment are described in Figure 10 of \[[@ref017]\] and are summarized on [Figure 1](#isb-13-isb190471-g001){ref-type="fig"}D. In this experiment, once a cell culture has been switched to the DM17 medium, it can be switched back to the LM1 medium. Switching back after 24 hours of differentiation does not cancel the self-renewing ability of the progenitors, but switching back after 48 hours does: instead of proliferating again, the culture stagnates. This means that there must remain some self-renewing cells in the culture after one day, but that they all have started differentiating after two days.

2.2. Models {#sec0045}
-----------

### 2.2.1. Structural Model {#sec0050}

We propose three alternative dynamic models of the erythroid differentiation, which are summarized on [Figure 2](#isb-13-isb190471-g002){ref-type="fig"}.

![Diagrams of three possible dynamic models for our data. A: The SB model has no intermediary compartment. B: The S2B model has no intermediary compartment, but the self-renewing cells change proliferation rate in DM17. C: The SCB model has an intermediary compartment.](isb-13-isb190471-g002){#isb-13-isb190471-g002}

The SB model comprises only two compartments ([Figure 2](#isb-13-isb190471-g002){ref-type="fig"}A), a self-renewing one (S) and a differentiated one (B, which stands for *benzidine-positive*), whose dynamics are given by the equations:

$$\begin{array}{rcl}
\frac{\mathit{dS}}{\mathit{dt}} & = & {\rho_{S}S\left( t \right) - \delta_{\mathit{SB}}S\left( t \right),\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\left( 1a \right)} \\
{\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\frac{\mathit{dB}}{\mathit{dt}}} & = & {\rho_{B}B\left( t \right) + \delta_{\mathit{SB}}S\left( t \right).\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\left( 1b \right)} \\
\end{array}$$

This model is characterized by a set *θ* = (*ρ*~*S*~, *δ*~*SB*~, *ρ*~*B*~) of three parameters, where *ρ*~*i*~ is the net proliferation rate of compartment *i*. For estimation-related reasons, it incorporates the balance between cell proliferation and cell death. This means that *ρ*~*i*~ can be either positive (more proliferation than death) or negative (more death than proliferation). On the other hand *δ*~*ij*~ is the differentiation rate of cell type *i* into cell type *j*, which is positive.

The S2B model comprises also the S and B compartments ([Figure 2](#isb-13-isb190471-g002){ref-type="fig"}B), but allows the self-renewing cells to change their net proliferation rate upon culture medium switching. This formulation arose from the consideration that proliferation is faster in the DM17 than in the LM1 medium ([Figure 1](#isb-13-isb190471-g001){ref-type="fig"}C). The dynamics of this model are given by the equations:

$$\begin{array}{rcl}
 & & {\frac{\mathit{dS}_{\mathit{LM}1}}{\mathit{dt}} = \rho_{\mathit{LM}1}S_{\mathit{LM}1}\left( t \right),\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\left( 2a \right)} \\
 & & {\frac{\mathit{dS}_{\mathit{DM}17}}{\mathit{dt}} = \rho_{\mathit{DM}17}S_{\mathit{DM}17}\left( t \right) - \delta_{\mathit{SB}}S_{\mathit{DM}17}\left( t \right),\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\left( 2b \right)} \\
 & & {\frac{\mathit{dB}}{\mathit{dt}} = \rho_{B}B\left( t \right) + \delta_{\mathit{SB}}S_{\mathit{DM}17}\left( t \right).\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\left( 2c \right)} \\
\end{array}$$

It is characterized by the set (*ρ*~*LM*1~, *ρ*~*DM*17~, *δ*~*SB*~, *ρ*~*B*~) of four parameters, following the same notation convention as in the SB model.

Finally, the SCB model ([Figure 2](#isb-13-isb190471-g002){ref-type="fig"}C) also comprises the same self-renewing and differentiated compartments as the SB model, as well as a hypothetical *committed cells* compartment *C*. This compartment comprises intermediary cells that are committed to differentiation, yet not fully differentiated. The dynamics of these three compartments are given by the equations:

$$\begin{array}{rcl}
{\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\frac{\mathit{dS}}{\mathit{dt}}} & = & {\rho_{S}S\left( t \right) - \delta_{\mathit{SC}}S\left( t \right),\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\left( 3a \right)} \\
{\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\frac{\mathit{dC}}{\mathit{dt}}} & = & {\rho_{C}C\left( t \right) + \delta_{\mathit{SC}}S\left( t \right) - \delta_{\mathit{CB}}C\left( t \right),\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\left( 3b \right)} \\
{\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\frac{\mathit{dB}}{\mathit{dt}}} & = & {\rho_{B}B\left( t \right) + \delta_{\mathit{CB}}C\left( t \right).\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\mspace{9mu}\left( 3c \right)} \\
\end{array}$$

It is characterized by the set (*ρ*~*S*~, *δ*~*SC*~, *ρ*~*C*~, *δ*~*CB*~, *ρ*~*B*~) of five parameters, following the same naming convention as the two other models.

Moreover, it should be noted that differential systems (1) to (3) are fully linear, and that their matrices are lower-triangular, which makes them easily solvable analytically. Their simulation is thus very fast. The detail of the analytical solutions to these systems is given as supplementary material.

Finally, not all variables in the models can be measured through the experiments that we presented in section 2.1, and we only have access to two observables of the system: the total amount of living cells *T* (*t*) through trypan blue staining, and the amount of differentiated cells *B* through benzidine staining. The number of living cells *T* can be measured in LM1 and in DM17, yet in LM1 there is no differentiation, so in the LM1 experiment *T* = *S* (or *T* = *S*~*LM*1~ in the S2B model). The number of differentiated cells *B* can be measured in DM17 (it is null in LM1).

### 2.2.2. Error Model {#sec0055}

In order to properly define the likelihood of our model, we need to define a statistical model for the prediction error of our dynamical model, *y* - *f* (*t*, *y*~0~, *θ*), where *y* is the data and *f* the prediction from the dynamical model (which depends on time *t*, the initial condition *y*~0~ and the parameters *θ* of the model). This prediction error is usually modelled by a gaussian distribution with a null mean \[[@ref022]\]. Then, the standard deviation of the error remains to be characterized.

When dealing with small datasets, a reasonable option is to build an additional model layer for the standard deviation of the error \[[@ref039]\]. This means finding a suitable function *g*, of the time *t*, the initial condition *y*~0~, the dynamical parameters *θ* and possibly other parameters *ξ* (which we will call the error parameters), to describe this variance. The error model is then completely described as: $\left. y_{i,j}\hookrightarrow\mathcal{N}\left( {f_{i}\left( t_{j},y_{0},\theta \right),g_{i}\left( t_{j},y_{0},\theta,\xi \right)} \right) \right.$. Several simple forms have been proposed for the function *g* \[[@ref040]\], that we summarize in Table 1. However, it is not obvious whether one should be used in general, or if the choice of *g* should be context-specific.

With this representation, the log-likelihood of the model follows as:

$$\begin{array}{rcl}
 & & {- 2\,\mathit{\log}\left( L \right) = \mathit{nm}\,\mathit{\log}\left( 2\pi \right) + \sum\limits_{i = 1}^{n}\sum\limits_{j = 1}^{m}\left( \frac{\left( {y_{i,j} - f_{i}\left( t_{j},\theta \right)} \right)}{g_{i}\left( t_{j},\theta,\xi \right)} \right)^{2}} \\
 & & {+ 2\mathit{\log}\left( g_{i}\left( t_{j},\theta,\xi \right) \right),} \\
\end{array}$$

where *n* is the number of variables of the dynamic model, and *m* the number of measurement points for each variable, and from which the *log* (2*π*) term is dropped. In the end, the best-fit parameters of the model are the values of *θ* and *ξ* which minimize the quantity defined in [Equation (4)](#eq4){ref-type="disp-formula"}. In this equation, the data *y*~*i*,*j*~ and the prediction *f*~*i*~ (*t*~*j*~, *θ*) are the total number of cells in each measured compartment of the model (without any transformation of the variables).

2.3. Parameter Estimation {#sec0060}
-------------------------

Considering the data at our disposal, we adopted the following procedure for parameter estimation:1.Estimate *ρ*~*S*~ (or *ρ*~*LM*1~ in the S2B model), and the corresponding error parameters *ξ*~1~ from the LM1 experiment. In LM1 there is no differentiation, so the *S* compartment just follows an exponential growth with rate *ρ*~*S*~.2.(a)In the SB model, set *δ*~*SB*~ so that there are no more self-renewing cells after 2 days of differentiation (which we interpret as *S* (48h) ≤1, *i.e.* $\delta_{\mathit{SB}} \geq \rho_{S} + \frac{1}{2}\mathit{\ln}\left( S\left( 0 \right) \right)$ from [Equation (1)](#eq1){ref-type="disp-formula"}).(b)In the SCB model, set *δ*~*SC*~ so that there are no more self-renewing cells after 2 days of differentiation (which we interpret as *S* (48h) ≤1, *i.e.* $\delta_{\mathit{SC}} \geq \rho_{S} + \frac{1}{2}\mathit{\ln}\left( S\left( 0 \right) \right)$ from [Equation (3)](#eq3){ref-type="disp-formula"}).3.Estimate the remaining parameters, and the corresponding error parameters *ξ*~2~, using the data from the DM17 experiment. In the SB model, the only remaining parameter is *ρ*~*B*~. In the S2B model, the remaining parameters are *ρ*~*DM*17~, *δ*~*SB*~ and *ρ*~*B*~. In the SCB model, these are *ρ*~*C*~, *δ*~*CB*~, *ρ*~*B*~.

The second step of this estimation sets *δ*~*SC*~ (*δ*~*SB*~ in the SB model) to a value such that there are no more self-renewing cells after 2 days of differentiation. This observation does not come from the cellular kinetics experiment that we presented on [Figure 1](#isb-13-isb190471-g001){ref-type="fig"}C. It rather uses the results of the commitment experiment (Section 2.1.5 & [Figure 1](#isb-13-isb190471-g001){ref-type="fig"}D), which shows that some self-renewing cells remain in the culture after one day, but that they all are differentiated after two days \[[@ref017]\].

In the SCB model, considering that the self-renewing compartment S is characterized by an exponential dynamic, and that there are no more self-renewing cells if and only if *S* ≤ 1, this provides an upper and a lower bound for *δ*~*SC*~:

$$\rho_{S} + \frac{1}{2}\mathit{\ln}\left( S_{0} \right)\, \leq \,\delta_{\mathit{SC}}\, \leq \,\rho_{S} + \mathit{\ln}\left( S_{0} \right).$$

For the sake of simplicity, we will set $\delta_{\mathit{SC}} = \rho_{S} + \frac{1}{2}\mathit{\ln}\left( S_{0} \right)$ in order to verify the equality: *S* (48h) =1 in the following. [Figures S2 and S3](#S1){ref-type="supplementary-material"} show that varying *δ*~*SC*~ between its two bounds does not refute our conclusions.

These considerations do not affect the S2B model, in which the switching of the culture medium only affects the proliferation rate of the S compartment.

In both estimation steps, the -log likelihood was minimized using the Truncated Newton's algorithm \[[@ref041]\] implemented in the python package for scientific computing scipy \[[@ref043]\]. Convergence to the global minimum was assured by a random sampling of the initial guesses for parameter values ([Figure S1](#S1){ref-type="supplementary-material"}).

2.4. Model Selection {#sec0065}
--------------------

In order to choose a proper error model, one needs to adopt a selection criterion, which allows to rank models and keep only the best ones, by balancing the quality of the fit of the models with their complexity.

We used a selection approach based on the corrected Akaike's Information Criterion (AICc, \[[@ref044]\]):

$$\mathit{AICc} = - 2\,\mathit{\log}\left( L \right) + \frac{2\mathit{kn}}{n - k - 1}.$$

where *k* is the number of parameters of the model and *n* is the sample size. The corrective term in *AICc* has been developed for linear models and small samples. However, since there is no selection criterion derived from *AIC* for non-linear models, the literature recommends using *AICc* when in doubt \[[@ref044]\].

From the AICc values of a set of models, we compute the corresponding Akaike's weights \[[@ref044]\]:

$$w_{i} = \frac{\mathit{\exp}\left( - \frac{\left( {\mathit{AICc}_{i} - \mathit{\min}\left( \mathit{AICc} \right)} \right)}{2} \right)}{\sum_{j = 1}^{R}\mathit{\exp}\left( - \frac{\left( {\mathit{AICc}_{i} - \mathit{\min}\left( \mathit{AICc} \right)} \right)}{2} \right)},$$

where *w*~*i*~ is the Akaike's weight of the i-th model, and *R* is the number of competing models. The Akaike's weight of a given model in a given set of models can be seen as the probability that it is the best one among the set \[[@ref044]\]. In this setting, selecting the best models of a set of models means computing their Akaike's weights, sorting them, and keeping only the models whose weights add up to a significance probability (for example, 95%).

2.5. Identifiability Analysis {#sec0070}
-----------------------------

We assessed the identifiability of our model using the method based on the statistical notion of profile likelihood \[[@ref022]\].

For a model with *k* parameters, a parameter space $\Theta = \left\{ {\left( \theta_{i},i \in \left\{ 1,2,\ldots,k \right\} \right),\mspace{9mu}\theta_{i} \in \mathbb{R}} \right\}$, and a likelihood *L*, the **profile likelihood** *PL*~*θ*~*i*~~ with respect to parameter *θ*~*i*~ is defined as:

$$\forall x \in \mathbb{R}\quad\mathit{PL}_{\theta_{i}}\left( x \right) = \max\limits_{\theta_{j \neq i}}\left( {L\left( \theta_{i} = x,\,\theta_{j} \right)} \right).$$

Namely, the profile likelihood with respect to a parameter at a certain value is the likelihood of the model, maximized with respect to all the other parameters. Computing the profile likelihood at a certain value *x* of a parameter *θ*~*i*~ means to set *θ*~*i*~ = *x* and to estimate the values of the other parameters *θ*~*j*~ that minimize the error -2 *log* (*L*) in this setting. Consequently, -2 *log* (*PL*) is minimal at the optimal parameter values set, and increases in both directions.

It is possible to define a **confidence interval** *CI*~*θ*~*i*~~ at a level of confidence *α* ∈\]0, 1 \[ for a parameter *θ*~*i*~, derived from the evaluation of the profile likelihood \[[@ref022]\]:

$$\mathit{CI}_{\theta_{i}}\left( \alpha \right) = \left\{ \left. x \in \mathbb{R}\mspace{9mu} \middle| \mspace{9mu} - 2\,\mathit{\log}\left( \mathit{PL}_{\theta_{i}}\left( x \right) \right) \right.\operatorname{} \right.\left. \operatorname{}{+ 2\,\mathit{\log}\left( \mathit{PL}_{\theta_{i}}\left( \widehat{x} \right) \right)\mspace{9mu} \leq \mspace{9mu}\chi^{2}\left( \alpha,k \right)} \right\},$$

where $\widehat{x}$ is the optimal estimate of *θ*~*i*~, *k* is the number of parameters being estimated and *χ*^2^ (*α*, *k*) is the *α*-quantile of the *χ*^2^ distribution with *k* degrees of freedom.

Namely, all the parameter sets that render a profile likelihood closer to its minimal value than a threshold *χ*^2^ (*α*, *k*) belong to the confidence interval.

A model is then **practically identifiable at the level of confidence** ***α*** if and only if the confidence intervals at level *α* of all of its parameters are bounded \[[@ref022]\]. In this study, we used *α* = 0.95.

The profile likelihood approach is a good way of addressing the identifiability of a model, because it allows to detect both structural and practical unidentifiabilities. This feature makes the approach more efficient in practice than most of the other methods in the field \[[@ref021]\].

3. Results & discussion {#sec0075}
=======================

3.1. Measurement error {#sec0080}
----------------------

The data that we used for the calibration of our models are displayed on [Figure 1](#isb-13-isb190471-g001){ref-type="fig"}C. For readability, it displays the total cell counts in log scale, and the differentiated cell counts as a fraction of the total count. This representation emphasises the fact that the measured cell population in LM1 decreases between 0h and 24h, in both conditions (control, and rapamycin-treated).

Every time-point displayed on [figure 1](#isb-13-isb190471-g001){ref-type="fig"}C was obtained by a single measurement, which increases the measurement error compared to a replicated experiment. We conclude that the observed decrease in the total living cell number in the LM1 medium (in both conditions) is due to the experimental error that the protocol suffers rather than to a hypothetical biological feature of the cells under study.

3.2. Fitting the model with no treatment: Model design and validation {#sec0085}
---------------------------------------------------------------------

### 3.2.1. Choosing a structural and an error model: selection approach {#sec0090}

By combining the three error models presented in [Table 1](#isb-13-isb190471-t001){ref-type="table"} with the three dynamic models presented in [Figure 2](#isb-13-isb190471-g002){ref-type="fig"}, it is possible to define 9 different models of our system. In order to choose the best one at reproducing the *in vitro* dynamics of erythropoiesis, we computed the maximum-likelihood estimates of the parameters of these nine models, (which are displayed in [Table S1](#S1){ref-type="supplementary-material"}).

###### 

Definition of three different error models \[[@ref040]\]

  Error model          Definition of *g*                                                                       Error parameters
  -------------------- --------------------------------------------------------------------------------------- ------------------
  Constant error       ∀ *j* *g*~*i*~ (*t*~*j*~) = *a*                                                         *ξ* = (*a*)
  Proportional error   ∀ *j* *g*~*i*~ (*t*~*j*~, *y*~0~, *θ*) = *b* . *f*~*i*~ (*t*~*j*~, *y*~0~, *θ*)         *ξ* = (*b*)
  Combined error       ∀ *j* *g*~*i*~ (*t*~*j*~, *y*~0~, *θ*) = *a* + *b* . *f*~*i*~ (*t*~*j*~, *y*~0~, *θ*)   *ξ* = (*a*, *b*)

For each of these nine models, we computed the likelihood-based selection criteria that are displayed on [Table 2](#isb-13-isb190471-t002){ref-type="table"}. The S2B and SCB dynamic models with a proportional error appear as the best ones and offer very similar fits. All other models are far worse (their Akaike's weights add up to around 4 × 10^-4^) but it remains impossible, based on this criterion, to decipher which of the two remaining models should be used to best describe the *in vitro* erythropoiesis.

###### 

Selection criteria evaluated for the nine possible pairs of error model and dynamic model

  --------------- -------------- ------------- ------------- --- ----- ---------- ------------- ---------------
  Dynamic model   Error model     -2*log*L~1~   -2*log*L~2~   k   AIC   AIC~*c*~   *Δ*AIC~*c*~   *w*~AIC~*c*~~
  SB              constant            107           228       4   343     347          45        8.9 × 10^-11^
  SB              proportional        106           199       4   313     317          15        2.5 × 10^-4^
  SB              combined            106           199       6   317     328          26        1.3 × 10^-6^
  S2B             constant            107           195       6   314     324          22        7.6 × 10^-6^
  S2B             proportional        106           174       6   291     302           0            0.55
  S2B             combined            106           174       8   295     319          18        8.7 × 10^-5^
  SCB             constant            107           195       6   314     325          23        6.7 × 10^-6^
  SCB             proportional        106           174       6   292     302         0.40           0.45
  SCB             combined            106           174       8   296     320          18        7.1 × 10^-5^
  --------------- -------------- ------------- ------------- --- ----- ---------- ------------- ---------------

L~1~ is the log-likelihood of the model for the LM1 data. L~2~ is the log-likelihood of the model for the DM17 data. k is the number of estimated parameters in each of the models, according to the procedure described in section 2.3. For each model, the sample size is n = 15. *AIC* = -2 log L~1~ - 2 log L~2~ + 2*k* is the Akaike's Information Criterion \[[@ref044]\]. AIC~*c*~ is the corrected AIC ([Equation (6)](#eq6){ref-type="disp-formula"}). *Δ*AIC~*c*~ = AIC~*c*~ - min(AIC~*c*~) is the AIC~*c*~ difference. *w*~AIC~*c*~~ is the Akaike's weight ([Equation (7)](#eq7){ref-type="disp-formula"}).

However, the S2B model does not describe the results of the commitment experiment ([Figure 1](#isb-13-isb190471-g001){ref-type="fig"}D). In this model indeed, self-renewing cells switch between different self-renewing rates upon medium switching. As a consequence, switching the cells back and forth between the two media should just switch their proliferation rate, without affecting their proliferation ability. So the cells would never lose their proliferation ability, as opposed to the result of the commitment experiment.

On the other hand, the SCB model predicts that upon switching to the differentiation medium, the cells from the S compartment start differentiating. Once they are all differentiated, cells from the C and B compartments can still proliferate, but this proliferation might be cancelled by a switch back to the LM1 medium. It is thus impossible to describe the process of commitment with the S2B model, while it is possible with the SCB model.

As a conclusion, the SCB model with a proportional error is the best-fitting model which also accounts for the results of the commitment experiment, making it our dynamic model of choice for the rest of this study.

### 3.2.2. Identifiability analysis {#sec0095}

In order to use a model for predictive purposes, one needs to assess its identifiability. The profile likelihood curves of all estimated parameters are displayed on [Figure 3](#isb-13-isb190471-g003){ref-type="fig"}, for the SCB model with proportional error. For *ρ*~*S*~ and *b*~1~, which are estimated together, the identifiability threshold at confidence *α* = 0.95 is *χ*^2^ (0.95, 2) =5.99. For *ρ*~*C*~, *δ*~*CB*~, *ρ*~*B*~ and *b*~2~, which are also estimated together, the threshold is *χ*^2^ (0.95, 4) =9.49.

![The SCB model with proportional error is fully identifiable. Solid curves are the profile likelihood curves of each estimated parameter of the model. Dashed lines give the identifiability threshold of each parameter at confidence level *α* = 0.95.](isb-13-isb190471-g003){#isb-13-isb190471-g003}

For every parameter of the model, the profile likelihood curve crosses the threshold on both sides of the optimum, which means that every parameter of the model is identifiable, at the level of confidence *α* = 0.95. The confidence intervals of the parameters \[[@ref022]\], extracted from these profiles ([Equation (9)](#eq9){ref-type="disp-formula"}) are displayed in [Table 3](#isb-13-isb190471-t003){ref-type="table"}.

###### 

Confidence Intervals of the parameters of the SCB model with proportional error.

  Parameter          Lower bound   Optimal value   Upper bound
  ----------------- ------------- --------------- -------------
  *ρ*~*S*~              0.35           0.53           0.70
  (doubling time)        24             31             48
  *b*~1~                0.18           0.34            1.1
  *δ*~*SC*~              5.6            \-             11
  (half-life)             2             \-              3
  *ρ*~*C*~              0.049          0.49           0.80
  (doubling time)        21             31             340
  *δ*~*CB*~             0.11           0.18           0.34
  (half-life)            49             92             150
  *ρ*~*B*~              0.44           0.92            1.3
  (doubling-time)        13             18             38
  *b*~2~                0.081          0.15           0.41

Highlighted in gray are the confidence interval boundaries at level *α* = 0.95, extracted from [Fig. 3](#isb-13-isb190471-g003){ref-type="fig"}, and the best-fit estimate of all the parameters of the model (expressed in d^-1^). For *δ*~*SC*~, which is not estimated, no optimal value can be computed, but absolute bounds on its values can be computed with [Equation (5)](#eq5){ref-type="disp-formula"}. Parameters are grouped by their estimation step in our procedure: *ρ*~*S*~ and *b*~1~ are estimated together in the first step, then *δ*~*SC*~ is set, and finally the four other parameters are estimated together. For the proliferation rates *ρ*~*S*~, *ρ*~*C*~ and *ρ*~*B*~, we also give the corresponding doubling times of the populations in hours (*i.e.* how long would it take to double the population in the absence of differentiation?). For the differentiation rates *δ*~*SC*~ and *δ*~*CB*~, we also give the half-life of the corresponding populations in hours (*i.e.* how long would it take to differentiate half the cells from the undifferentiated population, in the absence of proliferation?)

For a given parameter, the size of the confidence interval depends on the number of parameters that are estimated together, the required level of confidence, and the likelihood function used for the computation. By definition ([Equation (8)](#eq8){ref-type="disp-formula"}), the profile likelihood renders as large of a confidence interval as possible, because it increases as slowly as possible on each side of the optimal parameter value. This means that identifiability is harder to satisfy with the profile likelihood approach than with other definitions, for example based on a linearization of the likelihood surface at the optimal parameter set \[[@ref022]\].

As a consequence, the fact that the parameter confidence intervals presented in [Table 3](#isb-13-isb190471-t003){ref-type="table"} may appear as quite large is not a sign that the parameters are poorly estimated. It is rather the evidence that they remain identifiable even with a very stringent definition of identifiability, and at a high level of confidence.

It is not possible to study the identifiability of *δ*~*SC*~, since it is not estimated from the data. However, the commitment experiment ([Figure 1](#isb-13-isb190471-g001){ref-type="fig"}D) give us access to a lower and an upper bounds for its value ([Equation (5)](#eq5){ref-type="disp-formula"}). We determined the optimal likelihood of the model, and its optimal parameters in this range of value ([figures S1 and S2](#S1){ref-type="supplementary-material"}), showing that the choice of *δ*~*SC*~ does not influence the dynamics of our model.

3.3. Modelling differentiation in the control case {#sec0100}
--------------------------------------------------

A simulation of the model with the identified values of its parameters is reproduced, with the corresponding experimental data, on [Figure 5](#isb-13-isb190471-g005){ref-type="fig"}A. The overall quality of the fit is good, especially for the DM17 populations.

The precise values of each parameter of the model are reported in [Table 3](#isb-13-isb190471-t003){ref-type="table"}. The proliferation rate of the committed cells is slightly lower than the one of the self-renewing cells (the net doubling-time of the committed compartment is about 34h, whereas the doubling-time of the self-renewing compartment is around 31h). The differentiated cells proliferate with a higher rate (their doubling time is about 18h). Taken together, these doubling times explain the faster proliferation of cells in the DM17 medium than in the LM1, in agreement with previous data \[[@ref035]\]. Finally, the self-renewing cell differentiation is very fast: the lowest possible value of *δ*~*SC*~ gives them a half-life of 3h in DM17. This means that half of the S compartment would differentiate every 3h in the absence of proliferation. On the contrary, the differentiation of the committed cells is much slower (if they stopped proliferating, they would have a half-life of 90h).

The timescales at which these processes occur are pictured on [Figure 5](#isb-13-isb190471-g005){ref-type="fig"}B, which displays the number of cells in each state during a simulation of the model. As specified by the setting of the value of *δ*~*SC*~, the population of self-renewing cells quickly collapses, and the culture becomes a mixture of committed and differentiated cells. Both of these compartments then grow at their own rate.

At this stage, we have developed a very simple model of erythroid differentiation, that accounts well for the data used to calibrate it. Plus, it is fully identifiable (at confidence level 95%). We thus use it to study the effect of rapamycin, a drug known to affect the *in vitro* erythroid differentiation \[[@ref036]\].

3.4. Modelling differentiation under Rapamycin treatment {#sec0105}
--------------------------------------------------------

Rapamycin is known to increase the proportion of differentiated cells in cultures of chicken erythroid progenitors \[[@ref036]\] ([Figure 1](#isb-13-isb190471-g001){ref-type="fig"}C). Yet this effect might have several origins: a decreased mortality of the differentiated cells, or an increased differentiation rate for example. To decipher between these different possible effects of the rapamycin treatment, we estimated the values of the parameters of our model in the rapamycin treated case.

To avoid an overparameterization of the rapamycin effect, we considered that for each estimated parameter of the model, the value under rapamycin treatment could be either equal to the value in the untreated case, or equal to another value yet to be estimated. The first option would not introduce a new parameter in the model, but the latter would. Our model has seven parameters (5 dynamical parameters and 2 error parameters), of which 6 only are estimated (since *δ*~*SC*~ is entirely determined by the value of *ρ*~*S*~). This means that we can define 2^6^ = 64 models of rapamycin treatment, by keeping some of the parameters unchanged compared to the untreated case, and re-estimating the others with the data presented on [Figure 1](#isb-13-isb190471-g001){ref-type="fig"}C.

![Modelling erythropoiesis under rapamycin treatment. A. Akaike's weights of the three best models of the rapamycin treatment. The 61 other models are not displayed for readability. B. Parameter values in the best model of rapamycin treatment. Red dots are the ratio of the parameter values under rapamycin treatment with their values in the untreated case. Black straight lines represent the confidence intervals of the values in the untreated case, computed from [Figure 3](#isb-13-isb190471-g003){ref-type="fig"}. Red straight lines represent the confidence intervals at *α* = 95% of the values in the treated case, computed with the Profile Likelihood as well ([Figure S4](#S1){ref-type="supplementary-material"}). The dashed line indicates the parameter values in the untreated case, by which all parameters are scaled for readability.](isb-13-isb190471-g004){#isb-13-isb190471-g004}

![The model reproduces the cellular kinetics observed *in vitro*. A: Simulation of the SCB model with proportional error in the untreated (black) and rapamycin-treated cases (red). Solid lines represent a simulation of the SCB model with proportional error, with its best-fit parameters. Dots are the experimental data in the untreated condition. Triangles are the experimental data under rapamycin treatment. Displayed are the total number of living cells in LM1 and DM17 media (in log-scale), and the fraction of differentiated cells in DM17, although the fit was performed on the raw cell numbers. B-C: Numbers of cells in each compartment as a function of time in the untreated (B) and treated (C) cases.](isb-13-isb190471-g005){#isb-13-isb190471-g005}

We thus estimated the parameters of these 64 possible models of the treatment, and computed their likelihood-based selection criteria, the same way as we did for the dynamic model and the error model (see section 3.2). The Akaike's weights of the best three of these models are shown on [Figure 4](#isb-13-isb190471-g004){ref-type="fig"}A. The best model of the treatment is responsible for 94 % of the weight of the 64 models, making it by far the best model for the rapamycin treatment. A simulation of this model is displayed on [Figure 5](#isb-13-isb190471-g005){ref-type="fig"}, which indeed shows the quality of its fit to the data obtained under rapamycin treatment.

This model is obtained by varying all the parameter values except *b*~1~, compared to the control case, as displayed on [Figure 4](#isb-13-isb190471-g004){ref-type="fig"}B. Moreover, we computed confidence intervals for the parameters that vary under the treatment, showing that all these parameters are identifiable at *α* = 0.95 ([Figure S4](#S1){ref-type="supplementary-material"}). The confidence intervals of *ρ*~*S*~, *δ*~*CB*~, *ρ*~*B*~ and *b*~2~ show very little overlap with their confidence intervals in the control case, showing the strength of the treatment effects. The three proliferation rates *ρ*~*S*~, *ρ*~*C*~ and *ρ*~*B*~ are reduced under the treatment, while the differentiation rate *δ*~*CB*~ is increased.

Finally, the effect of rapamycin on the distribution of cells between the different compartments is displayed on [Figure 5](#isb-13-isb190471-g005){ref-type="fig"}C. Under rapamycin, the C compartment decays, when it proliferated in the control case. Moreover the B compartment has a longer doubling time under rapamycin treatment (48h instead of 18h in the untreated case). These two effects explain why the drug treatment reduces the overall amount of cells and increases the proportion of differentiated cells in the culture.

4. Conclusion {#sec0110}
=============

We proposed a model for the *in vitro* erythroid differentiation, which comprises two components. First, the dynamic component is the set of ODE written in [Equation (3)](#eq3){ref-type="disp-formula"}, which describes the dynamics of three cell populations. Second, we added an error component which describes the distribution of the residuals of the dynamic model.

The three populations of our dynamical model are related to three different stages of differentiation of the progenitors. The first one is in a self-renewal state S where differentiation has not started, and the third one has finished differentiating. The second population lies in the middle, in a state of commitment C where cells are not fully differentiated yet, but cannot go back to self-renewal.

Similar 3-states models have already been used to describe differentiation \[[@ref019]\]. Their success probably stems from the fact that it would be difficult to describe differentiation as the transition between only 2 states, as we highlighted in the context of *in vitro* erythropoiesis with our SB model. Actually, differentiation from one cell type to another is a continuous process, so its best description would probably be a continuum of states, which would punctuate the transition between the two cell types \[[@ref019]\].

However, explicitly accounting for this continuum would require an infinity of intermediary states. For example, the levels of differentiation factors inside the cell could be used as a measure of its differentiation state \[[@ref048]\]. Such kind of a model should be able to describe differentiation more faithfully than ours. Yet our model, though simplistic, reproduces our experimental data quite well, and is identifiable. Moreover, since it is fully linear and thus analytically integrable, its simulation and calibration are very quick.

Such simplicity and identifiability of our model would probably make it valuable to describe differentiation in other contexts.

Once the model was chosen, we verified the accuracy of its parameter estimates. We showed that among the seven parameters of our model, the six that are estimated by the maximum-likelihood approach are identifiable, and that the choice of the seventh one does not alter the behaviour of the others. Using the Profile Likelihood approach, we computed confidence intervals for our parameters. Even though their relatively large size might be interpreted as a lack of accuracy in the estimates of the parameters, it is not the case since the identifiability of a parameter is harder to satisfy by the Profile-Likelihood approach than using other methods. We thus showed that our model is fully identifiable, even using a very stringent criterion.

After demonstrating the validity of our model in the control case, we used it to study the effect of rapamycin, a chemical drug which is known to impact the differentiation of erythroid progenitors \[[@ref036]\]. We designed 64 different models of the rapamycin treatment, which differ by the combinations of parameters that are affected by the treatment. Evaluating the quality of their fit to the data allowed us to retain only the best model of rapamycin treatment. The parameter values in this model reveal that rapamycin increases the differentiation rate of the intermediary cell compartment, and reduces the net growth rates of the three other compartments. This means that rapamycin increases the differentiation of the cells in culture, and also affects the balance between their proliferation and mortality. The reduced net proliferation rates might be caused by a reduced proliferation, an increased mortality or any joint variation of the two processes equivalent to one of these effects (e.g. reduced mortality, and an even more reduced proliferation).

In the context of other perturbations of differentiation (for instance, treating cultures with a different drug than rapamycin), should the drug influence be less strong, we might need a more subtle means of parameter evaluation, such as the fused lasso penalized regression \[[@ref050]\].

At the moment, our approach suffers one major drawback that is the size of our dataset. Indeed, the precision of our prediction of cell numbers at one time-point relies on the precision of our measures of these numbers. And this measurement precision is directly related to the number of repetitions of the measurements.

Repeating the same experiment several times would thus increase measurement precision and average out measurement noise. This would allow a more precise estimation of the error model parameters, and in turn would increase the precision of the dynamic model. What we call *repeating the same experiment* here does not simply consist in counting cells from the same time point several times to average out sampling biases. It rather involves putting new cells in culture and following their populations over time, as two full replicates of the experiment.

In this setting, the measurement error would not just be limited to technical noise due to the sampling of cells from the culture for counting. It would rather be related to differences between the kinetic features of the cells in culture, *i.e.* to actual biological heterogeneity. This heterogeneity would be averaged by the estimation of one parameter set to fit all the data.

One way of accounting for this heterogeneity in a model, without averaging it out during parameter estimation, is through the use of a mixed effect model, that is a mathematical model (e.g. a set of deterministic ODE, like ours) whose parameters are modeled by distributions of random variables \[[@ref040]\]. We are presently assessing the ability of such mixed effect models to characterize both the behaviour of the cells in culture on average, as well as their variability.
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